In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso

BACKGROUND: Artemisinin-based combination therapy (ACT) is recommended to improve malaria treatment efficacy and limit drug-resistant parasites selection in malaria endemic areas. 5 years after they were adopted, the efficacy and safety of artemether–lumefantrine (AL) and artesunate–amodiaquine (ASA...

Descripción completa

Detalles Bibliográficos
Autores principales: Lingani, Moussa, Bonkian, Léa Nadège, Yerbanga, Isidore, Kazienga, Adama, Valéa, Innocent, Sorgho, Hermann, Ouédraogo, Jean Bosco, Mens, Petronella Francisca, Schallig, Henk D. F. H., Ravinetto, Raffaella, d’Alessandro, Umberto, Tinto, Halidou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945612/
https://www.ncbi.nlm.nih.gov/pubmed/31906948
http://dx.doi.org/10.1186/s12936-019-3089-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945612/
https://www.ncbi.nlm.nih.gov/pubmed/31906948
http://dx.doi.org/10.1186/s12936-019-3089-z

Ejemplares similares